Results 121 to 130 of about 47,575 (169)
Some of the next articles are maybe not open access.
2021 Winter Simulation Conference (WSC), 2021
This paper analyzes a real-life distribution problem that is related to a pharmaceutical supplier in Spain. Every day, a fleet of vehicles has to deliver the previously requested items to a large set of pharmacies. The distribution has to be conducted with (i) the total distance and time incurred by the entire fleet being reasonably low and (ii) the ...
Herrera E. +4 more
openaire +2 more sources
This paper analyzes a real-life distribution problem that is related to a pharmaceutical supplier in Spain. Every day, a fleet of vehicles has to deliver the previously requested items to a large set of pharmacies. The distribution has to be conducted with (i) the total distance and time incurred by the entire fleet being reasonably low and (ii) the ...
Herrera E. +4 more
openaire +2 more sources
Considerations in establishing fees for home-care pharmaceutical services
American Journal of Health-System Pharmacy, 1989The activities of home-care pharmacists are highlighted, and factors that should be considered in establishing a reimbursement schedule are described. Pharmacists are important members of the home health-care team. Responsibilities of the pharmacist include assisting in the development of a therapeutic plan, reviewing and monitoring drug therapy, and ...
openaire +2 more sources
Manufacturing & Service Operations Management, 2012
Fee-for-service (FFS) contracts, first introduced in 2004, dramatically changed the way the pharmaceutical distribution supply chains are designed, managed, and operated. Investment buying (IB), forward buying in anticipation of drug price increases, used to be the way the distributors made most of their profits.
Hui Zhao +3 more
openaire +1 more source
Fee-for-service (FFS) contracts, first introduced in 2004, dramatically changed the way the pharmaceutical distribution supply chains are designed, managed, and operated. Investment buying (IB), forward buying in anticipation of drug price increases, used to be the way the distributors made most of their profits.
Hui Zhao +3 more
openaire +1 more source
US Prescription Drug User Fee Act (PDUFA): An Introduction for the Pharmaceutical Physician
Pharmaceutical Medicine, 2016Originally enacted to address the delays in US Food and Drug Administration (FDA) new drug review due to chronic understaffing and outdated systems, the Prescription Drug User Fee Act (PDUFA) of 1992, with its 5-year reauthorization cycle, enabled rapid rigorous review and ushered in a new era of continuing program innovation, evaluation, and ...
Theresa M. Mullin, Joshua L. Barton
openaire +1 more source
Improving Time to Pharmaceutical Approval: An Analysis of the Prescription Drug User Fee Act Process
Drug Information Journal, 2012The Prescription Drug User Fee Act of 1992 (PDUFA) established pharmaceutical review performance goals and authorized the US Food and Drug Administration (FDA) to collect user fees in conjunction with pharmaceutical marketing applications. There have been 3 subsequent reauthorizations of PDUFA; the most recent, referred to as PDUFA IV, was enacted with
Andrea C. Masciale +2 more
openaire +1 more source
Charging for hospital pharmaceutical services: Computerized system using a markup and a dose fee
American Journal of Health-System Pharmacy, 1979The methods used to determine pharmacy charges for a pricing program in a 940-bed hospital using a computerized on-line pharmacy pricing and inventory control system are described. The program requires input of only four pieces of information: (1) patient number; (2) drug identification number; (3) dose factor; and (4) total number of doses dispensed ...
openaire +2 more sources
Corporate Governance and Audit Fees of Listed Pharmaceutical Firms in Nigeria
2019This study aimed at ascertaining those corporate governance variables that determine the audit fees of listed pharmaceutical firms in Nigeria for a 6-year period from 2012 to 2017. The study adopts ex-post facto and Panel research design and secondary data are obtained from the annual audited accounts of the sample of seven (7) out of the population of
openaire +1 more source
Pharmaceutical Spending in Fee-for-Service Medicare
JAMA, 2022Walid F, Gellad, Inmaculada, Hernandez
openaire +2 more sources
Annals of Pharmacotherapy, 2006
Background: Since the early- to mid-1990s, drug companies have paid fees for a variety of activities carried out by the Therapeutic Products Directorate in Canada and the Therapeutic Goods Administration in Australia. Objective: To explore whether changes in approval times for new active substances and in the percentage of new drug submissions ...
openaire +2 more sources
Background: Since the early- to mid-1990s, drug companies have paid fees for a variety of activities carried out by the Therapeutic Products Directorate in Canada and the Therapeutic Goods Administration in Australia. Objective: To explore whether changes in approval times for new active substances and in the percentage of new drug submissions ...
openaire +2 more sources
Audit Client Characteristics and Audit Fees of Listed Pharmaceutical Firms in Nigeria
2019This study aimed at investigating the relationship between audit client characteristics and audit fees of listed pharmaceutical firms in Nigeria for a 6-year period from 2012 to 2017. The study adopted a historical research design and secondary data were obtained from the sample size of seven out of the population of eleven listed pharmaceutical firms ...
openaire +1 more source